TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE

Go back to TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE
(NASDAQ: RNAZ) Delayed: 2.87 -0.1 (3.37%)
Previous Close $2.97    52 Week High
Open $2.90    52 Week Low
Day High $3.00    P/E N/A 
Day Low $2.87    EPS
Volume 42,159